)
)
Imago BioSciences Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Imago BioSciences Inc
Access all reports
Imago BioSciences, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme used in the production of blood cells in the bone marrow. We are conducting clinical trials for bomedemstat which is being developed as a treatment for myeloproliferative neoplasms (MPNs).
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
IMGO
Country
🇺🇸 United States